![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
í
alDepartment of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
Received November 8, 2004; accepted January 11, 2005.
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
). Five subtypes of muscarinic receptors that share a high degree of homology in transmembrane segments while connecting extracellular loops displaying more diversity have been identified (Bonner et al., 1987, 1988; Peralta et al., 1987; Bonner, 1989a,b). Selectivity of individual subtypes for classical ligands and particularly for agonists is rather low because the orthosteric binding site is formed by highly homologous transmembrane segments (Lu et al., 2002; Hulme et al., 2003). Besides the classical binding site, muscarinic receptors possess one or more allosteric binding sites (Ellis and Seidenberg, 1989; Ellis et al., 1993; Lazareno et al., 2000; Christopoulos and Kenakin, 2002) whose binding determinants are located on less conserved extracellular loops. Binding of allosteric ligands can induce conformational changes of the receptor that result in changes in receptor affinity for orthosteric agonists and antagonists (Tuek et al., 1990, 1998; Pro
ka and Tuek, 1994; Dong et al., 1995; Jakubík et al., 1995, 1997; Lazareno and Birdsall, 1995). These effects exhibit remarkable receptor subtype selectivity that is also reflected in the functional outcome of receptor stimulation by orthosteric agonists (Lazareno and Birdsall, 1995; Doleal and Tuek, 1998; Birdsall et al., 1999; Lazareno et al., 2004). Allosteric interactions are usually more pronounced at M2 and M4 than at M1, M3, or M5 subtypes of muscarinic receptors (Christopoulos et al., 1999; Christopoulos and Kenakin, 2002), and at least in the case of the allosteric modulator gallamine this difference between M2 and M3 subtypes is not due to preferential coupling with G protein (Tränkle et al., 2001), which is largely determined by the third intracellular loop. Allosteric modulators are thus useful for identifying muscarinic receptor subtype that mediate specific physiological functions in native systems and also offer a great promise for developing strategies of subtype-selective therapeutic interventions.
Allosteric modulator-induced effects on orthosteric ligand affinity is characterized by a factor of cooperativity (
) that denotes direction and maximal change in binding affinity of the orthosteric ligand. The magnitude of is dependent on the pair of allosteric/orthosteric ligands and the receptor subtype. Cooperativity can be positive (allosteric modulator increases affinity for a given classical ligand), negative (allosteric modulator decreases affinity), or neutral (allosteric modulator binds to the receptor but does not change affinity for a given classical ligand). Mutagenesis studies have been used to reveal sensor sequences important for allosteric modulator affinity and cooperativity with classical ligands. These studies have used two different approaches, i.e., site-directed mutagenesis of specific receptor residues (Leppik et al., 1994; Matsui et al., 1995; Gnagey et al., 1999) or construction of hybrid receptors exploiting pharmacological differences among individual receptor subtypes (Ellis et al., 1993; Ellis and Seidenberg, 2000; Krejí and Tuek, 2001). Together, experimental evidence is consistent with the notion that the second and the third extracellular loop mainly determine properties of interaction of allosteric ligands with muscarinic receptors.
In recent experiments, we exploited the divergence of allosteric interactions at M2 and M3 subtypes (Krejí and Tuek, 2001). We found that complete exchange of the extracellular o2 loop (o2) of the M3 subtype of muscarinic receptor by the o2 loop of the M2 subtype increased affinity of the chimeric receptor (M3o2 chimera) for gallamine and alcuronium, but had no effect on their cooperativity with N-methylscopolamine (NMS) binding. Similar substitution of the extracellular o3 loop (M3o3 chimera) also increased affinity of the chimeric receptor for both allosteric modulators. Replacement of the o3 loop augmented negative cooperativity of gallamine and inverted negative cooperativity of alcuronium at parent M3 receptor to positive cooperativity on the donor M2 receptor. This was the first example of reversal of the direction of cooperativity that was accomplished by exchange of the defined segment of muscarinic receptor subtype displaying negative cooperativity for corresponding segment of a subtype exhibiting positive cooperativity (Krejí and Tuek, 2001).
Using the same approach in the present experiments, we investigated the influence of similar and additional mutations in the third extracellular loop (o3) of the M3 receptor subtype on mutual interactions of the classical ligand NMS and four closely related derivatives of strychnine (Fig. 1). We demonstrate that the o3 loop of the M3o3 chimera is responsible for the appearance of positive cooperativity between NMS and Wieland-Gumlich aldehyde (WGA) or brucine. Results of our experiments establish for the first time that substitution of as little as three amino acids in the third extracellular loop of the M3 subtype of muscarinic receptor by corresponding residues of the M2 subtype brings about positive cooperativity between NMS and WGA, whereas this compound exerts negative cooperativity on both parent subtypes. We show in addition that positive cooperativity of tested strychnine-like modulators on the chimeric receptor is conditioned by proper interaction with the o2 loop.
|
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Mutagenesis and Expression. Amino acids of the M3 receptor were always mutated to the corresponding residues of the M2 receptor (Fig. 2). Mutants of M3 receptor containing entire o2 or o3 loops of M2 sequence are named M3o2 and M3o3, respectively. For the sake of brevity, names of the rest of mutants consist of receptor subtype followed by a suffix of original amino acids in the third extracellular loop followed by the substituted amino acids. For example, M3SKFN
PNVT means that four amino acids (serine 519, lysine 523, phenylalanine 525, and asparagine 527) in the third extracellular loop of M3 receptor were mutated on proline, asparagine, valine, and threonine in M2 sequence (Fig. 2).
|
Wild-type genes for human muscarinic M2 and M3 receptors incorporated in pCD vector (kindly provided by Professor N. Buckley, University Leeds, Leeds, UK) were used. Construction of M3 receptor with the substituted M2 o2 or o3 loop and mutations (M3KN and M3KFNNVT) in the o3 loop was described in Krejí and Tuek (2001). Additional mutants were generated using QuikChange kit (Stratagene, La Jolla, CA). To replace serine 519 with proline, plasmid containing wild-type M3 receptor as template and 5'-TGA ACA CCT TTT GTG ACC CCT GCA TAC CCA AAA CCT TTT GG-3' primer were used. To obtain M3DKFNANVT, mutant plasmid containing M3KFNNVT mutant as template and 5'-GTG AAC ACC TTT TGT GCC AGC TGC ATA CCC AAT ACC-3' primer were used. To obtain M3SKPN, mutant plasmid containing M3 KN mutant as template and 5'-TGA ACA CCT TTT GTG ACC CCT GCA TAC CCA ATA CCT TTT GG-3' primer were used. To obtain M3SKFNPNVT, mutant plasmid containing M3KFNNVT mutant and 5'-TGA ACA CCT TTT GTG ACCCCT GCA TAC CCA ATA CCG TTT GG-3' primer were used. All mutated DNAs were sequenced with the dideoxy method by Dr. J. Felsberg (Academy of Sciences, Institute of Microbiology, Prague, Czech Republic).
COS-7 cells were transiently transfected with the use of the DEAE-dextran method. Cells were grown in 10-cm Petri dishes in Iscove's modified Dulbecco's medium (Sigma-Aldrich) with 10% fetal calf serum. On day 1, 2 x 106 cells were seeded per dish. On day 3, after washing with phosphate-buffered saline, the transfection mix (2 µg of plasmid DNA and 0.27 mg of DEAE-dextran in 1 ml of phosphate-buffered saline) was applied for 2 h. Seven milliliters of serum-free Iscove's modified Dulbecco's medium and chloroquine in a final concentration of 80 µM were then added for an additional 3 h. Transfection medium was then removed, and fresh medium supplemented with 10% fetal calf serum was applied. Cells were harvested 72 h after transfection.
Radioligand Binding Experiments. Radioligand binding experiments were performed on membranes of COS-7 cells. Membranes were obtained by dilution of freshly harvested COS-7 cells in a medium composed of 136 mM NaCl, 5 mM KCl, 1 mM MgCl2, and 10 mM Na-HEPES, pH 7.4, to a final concentration of 107 cells per milliliter. Cell suspension was then homogenized (Ultra-Turrax; Janke & Kunkel GmbH & Co. KG, IKA-Labortechnik, Staufen, Germany) at 0°C by two 30-s strokes. Homogenate was centrifuged for 20 min at 30,000g. Pellets were resuspended in 10 times original volume (before centrifugation), and centrifugation was repeated. Membranes were kept frozen at –20°C for a maximum of 1 month and rehomogenized just before experiment. Binding experiments to membranes from 1 to 2 million cells per tube were done as described previously (Jakubík et al., 1995). The medium used for incubation was the same as described above, and incubation volume was 0.8 ml. Incubations were performed at 25°C and were terminated by filtration through Whatman GF/C glass fiber filters in a Brandel filtration apparatus (Sensat, Hatsfield, Hertshire, UK). Nonspecific binding was determined in the presence of 1 µM NMS.
The affinity of wild-type and mutated muscarinic receptors for [3H]NMS was measured in saturation binding experiments (1-h incubation at 25°C with [3H]NMS, at concentrations ranging from 25 pM to 1 nM) and expressed as Kd (equilibrium dissociation constant for the binding of [3H]NMS). The apparent dissociation constants, KA, of receptors for allosteric ligands and factors of cooperativity between allosteric ligand and [3H]NMS were determined in competition-type experiments in which membranes were preincubated in the presence of 200 pM [3H]NMS for 1 h at 25°C, and then increasing concentrations of the allosteric ligand were added and incubation was continued for an additional 5 h.
Dissociation constants koff in the absence and presence of allosteric ligands displaying neutral cooperativity with [3H]NMS were examined in a procedure modified from Lysíková et al. (1999). Membranes were preincubated for 1 h with [3H]NMS at a concentration corresponding to twice its Kd value. Brucine or WGA in concentrations ranging from 0.01 to 1 mM were added, and preincubation was continued for an additional 5 h. Dissociation was started by addition of NMS at a final concentration of 5 µM. Dissociation was stopped after 10 and 30 min, and koff values based on two-point determinations were computed for each concentration of the allosteric modulator.
Data Treatment. Data were processed and analyzed with open source software OpenOffice 1.0.2 (OpenOffice Foundation; www.openoffice.org) and Grace 5.1.12 (Grace Development Team; plasmagate.weizmann.ac.il/Grace) on Mandrake distribution of Linux (www.mandrake.com). The equations for nonlinear regression analysis were as follows.
Saturation binding experiments. After subtraction of nonspecific binding, eq. 1 was fitted to the data:
 | (1) |
Competition-type experiments. After subtraction of nonspecific binding and normalization (to express the binding of [3H]NMS in the presence of allosteric ligand as percentage of the binding in the absence of allosteric ligand), eq. 2 was fitted to the data:
 | (2) |
is the cooperativity factor between allosteric ligand and [3H]NMS (Ehlert, 1988).
Dissociation experiments. After subtraction of nonspecific binding and normalization (to express the binding of [3H]NMS at a given time as percentage of the binding at time 0), eq. 3 was fitted to the data:
 | (3) |
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
; Lysíková et al., 1999) and COS-7 cells (Krejí and Tuek, 2001). Mutation of three (M3KFNNVT) or more residues in the o3 loop of the M3 receptor increased the Kd value for [3H]NMS, and exchange of the complete o3 loop led to a Kd value for [3H]NMS similar to that of the M2wt receptor. However, exchange of the complete second extracellular loop had no influence on affinity (Table 1). This is in agreement with a previous finding (Krejí and Tuek, 2001).
|
Interaction of [3H]NMS and Allosteric Modulators. We tested four closely related chemicals: strychnine, its dimethoxy derivate brucine, strychnine synthesis precursor WGA, and its derivative propargyl-WGA as allosteric modulators of [3H]NMS binding to M2wt, M3wt, and mutated M3 subtypes of muscarinic receptors (Fig. 1). These compounds displayed a variety of cooperativities with [3H]NMS. Thus, there was relatively strong negative cooperativity on both wild subtypes by propargyl-WGA with weaker negative cooperativity by WGA on both subtypes. In contrast, brucine exhibited weak negative cooperativity on M3wt and positive cooperativity on M2wt receptors, whereas strychnine had positive cooperativity on both receptor subtypes (Table 1; Fig. 3). Tested modulators also differed in affinities for M2wt and M3wt receptors. Propargyl-WGA had 30 times higher affinity for the M2wt than for the M3wt receptor, whereas affinity of WGA was only 2 times higher at the M2 than the M3 receptor. Affinity of brucine was equal at both receptor subtypes, and the affinity of strychnine was slightly (2 times) lower on the M2 than on the M3 subtype (Table 1).
|
Effects of Exchange of the Entire o2 or o3 Loop between M2 and M3 Receptors on Affinity and Cooperativity of Allosteric Modulators. Strychnine displayed positive cooperativity with [3H]NMS on both M2wt and M3wt receptors and had higher affinity for M3wt than for M2wt receptors. Exchange of the entire o2 loop of the M3wt receptor by the M2 sequence (M3o2 chimera) had no effect on the affinity of strychnine and slightly enhanced positive cooperativity between strychnine and [3H]NMS. Replacement of the entire o3 loop of the M3wt receptor with the M2 sequence (M3o3 chimera) also decreased affinity of strychnine below the value of M2wt receptor and enhanced positive cooperativity between strychnine and [3H]NMS. Resulting positive cooperativity on M3o3 chimera was significantly stronger than on M2wt receptor (Table 1; Fig. 3A).
Brucine had negative cooperativity with [3H]NMS binding on M3wt but positive cooperativity on M2wt. Both M3wt and M2wt receptors showed the same affinity for brucine. Exchange of the entire o2 loop had no effect either on affinity for brucine or cooperativity between brucine and [3H]NMS. Substitution of the entire o3 loop had no effect on affinity but reversed the negative cooperativity between brucine and [3H]NMS on parental M3wt receptor to positive cooperativity. As for strychnine, resulting positive cooperativity on chimeric M3o3 receptor was even stronger than on M2wt receptor (Table 1; Fig. 3B).
WGA exhibited negative cooperativity with [3H]NMS on both M3wt and M2wt receptors and had 2 times lower affinity for M3wt than for M2wt receptor. Exchange of the o2 loop had no effect on affinity of WGA or on its cooperativity with [3H]NMS. In contrast, exchange of the o3 loop increased affinity for WGA 4 times. Strikingly, the resulting M3o3 chimera exerted positive cooperativity between WGA and [3H]NMS, despite that parent M2wt as well as M3wt receptor demonstrated negative cooperativity. Because the negative cooperativity at the donor M2wt receptor is larger than that at the acceptor M3wt receptor, one would have expected enhanced negative cooperativity of WGA at the M3o3 chimera (Table 1; Fig. 3C).
Propargyl-WGA showed strong negative cooperativity on both M3wt and M2wt receptors and had more than 30 times lower affinity for M3wt than M2wt receptor. M3o2 chimera had more than 4 times higher affinity for propargyl-WGA than M3wt receptor. Cooperativity between propargyl-WGA and [3H]NMS on the M3o2 chimera was significantly weaker compared with both M3wt and M2wt receptors. Replacement of the o3 loop of M3 receptor brought about much stronger increase in affinity for propargyl-WGA than exchange of the o2 loop. Affinity of propargyl-WGA was about 40 times higher on M3o3 chimera than on M3wt and about 10 times higher than on M3o2 chimera. However, unlike other tested allosteric modulators, the effect of exchange of the o3 loop on cooperativity between propargyl-WGA and [3H]NMS was smaller than the effect of exchange of the o2 loop (Table 1; Fig. 3D).
Together, complete replacement of the M2o2 loop in the M3 receptor had no effect on the affinity of strychnine, brucine, and WGA. However, exchange of the o3 loop, with the exception of brucine, changed affinity of all other allosteric modulators. The general direction of these changes was always toward the values of the M2wt receptor, and in the case of strychnine and WGA, the affinity of the M3o3 chimera even surpassed that of the M2wt receptor. Exchange of the o3 loop affected cooperativity of binding with [3H]NMS of all tested allosteric modulators. In contrast, replacement of the o2 loop significantly influenced cooperativity with [3H]NMS only of strychnine and propargyl-WGA. Only propargyl-WGA showed stronger change of cooperativity at the M3o2 than the M3o3 chimera.
Effects of Specific Mutations in the o3 Loop. Because of the profound effects that exchange of the entire o3 loop of M3wt receptor has demonstrated on the binding characteristics of various allosteric modulators (Krejí and Tuek, 2001; this report), the role of individual amino acids was studied in detail by their gradual mutations. We have started with two single mutations. Serine 519 was mutated to proline (M3SP) and lysine 523 was mutated to asparagine (M3KN). Subsequently, these mutations were combined (M3SKPN), with or without additional mutations in the o3 loop of the M3 receptor (M3KFNNVT, M3DKFNANVT, and M3SKFNPNVT) to gradually match M2 sequence (for numbering of amino acids, see Fig. 2).
Strychnine had positive cooperativity with [3H]NMS on both subtypes and higher affinity for M3wt than M2wt receptor. As mentioned above, exchange of the entire o3 loop of M3wt receptor decreased affinity for strychnine below the value of the M2wt receptor and enhanced positive cooperativity with [3H]NMS above the value of M2wt receptor (Table 1; Figs. 3A and 4). Although none of the single mutations had comparable effect on affinity as replacement of the entire o3 loop, mutation of only one amino acid M3KN (at position 523) significantly increased cooperativity of strychnine with [3H]NMS, and replacement of just two amino acids M3SKPN (at positions 519 and 523) decreased affinity for strychnine in addition to increasing cooperativity to the value of M2wt receptor. Mutation of only three amino acids (lysine 523 to asparagine, phenylalanine 525 to valine, and asparagine 527 to threonine; M3KFNNVT) augmented positive cooperativity between strychnine and [3H]NMS to the value of M2wt receptor, and additional mutations to this triple-mutant further increased this positive cooperativity.
|
Brucine displayed negative cooperativity on M3wt receptor and positive cooperativity on M2wt receptor and has the same affinity for both subtypes. Exchange of the entire o3 loop of M3wt receptor with M2 sequence did not change affinity for brucine, but it reversed negative cooperativity between brucine and [3H]NMS to positive cooperativity that was even higher than on the donor M2wt receptor (Table 1; Figs. 3B and 4). Mutation of just two amino acids (M3SKPN) was sufficient to change negative cooperativity to positive cooperativity, and mutation of three amino acids (M3KFNNVT) had the same effect as exchange of the entire o3 loop. Due to the neutral cooperativity between brucine and [3H]NMS, affinity of M3KN mutant for brucine was determined in dissociation experiments. Mutant M3KN has similar affinity to M3wt (pKA = 3.99 and 4.00 in two independent experiments performed in triplicates; data not shown).
WGA exhibited negative cooperativity on both M2wt and M3wt receptor and had 2 times higher affinity for M2wt than for M3wt receptor. Exchange of the entire o3 loop of M3 receptor with M2 sequence increased affinity 4 times to a value significantly higher than that of M2wt receptor and changed cooperativity between WGA and [3H]NMS from negative to positive (Table 1; Figs. 3C and 4). Single mutation of M3KN changed negative cooperativity to neutral and mutation of three amino acids M3KFNNVT changed negative cooperativity of M3wt receptor to positive without changing affinity for [3H]NMS. Replacement of four amino acids M3DKFNANVT brought about an increase of affinity for WGA that became higher than at M2wt receptor and further enhanced positive cooperativity so that both affinity and cooperativity of WGA equaled that of M3o3 chimera. Due to neutral cooperativity between WGA and [3H]NMS, affinity of M3KN and M3SKPN mutants for WGA was determined in dissociation experiments. Mutant M3KN (pKA = 3.93, 3.95) as well as M3SKPN (pKA = 3.99, 4.00; two independent experiments in triplicates; data not shown) had lower affinity than M3wt. However, it should be noted that affinities of allosteric ligands determined by dissociation experiments do not always strictly correspond to those determined in competition-type experiments (Krejí and Tuek, 2001).
Similar to WGA, propargyl-WGA displayed negative cooperativity with [3H]NMS on both M3wt and M2wt receptor that is stronger on M3wt receptor. M2wt receptor had 30 times higher affinity for propargyl-WGA than M3wt receptor (Table 1; Figs. 3D and 4). Exchange of the entire o3 loop of M3 receptor increased affinity for propargyl-WGA and reduced negative cooperativity between propargyl-WGA and [3H]NMS. Similar to WGA, the orientation of change in cooperativity was in the opposite direction than at wild subtypes, but, unlike WGA, it did not reach positive values. Mutation of just one amino acid (M3KN) made cooperativity between propargyl-WGA and [3H]NMS significantly weaker and increased affinity for propargyl-WGA (Table 1; Fig. 4, A and B). Replacement of four amino acids M3DKFNANVT resulted in change of affinity for propargyl-WGA as well as of its cooperativity with [3H]NMS to the value at M3o3 chimera.
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
) who showed that mutation of aspartate 71 in the second transmembrane segment of the M1 receptor, an amino acid far away from the allosteric binding site, decreases affinity for the allosteric modulator gallamine. Similarly, changes of NMS dissociation rate from M2 receptor modified in the second and the third extracellular loops has been reported (Buller et al., 2002; Voigtländer et al., 2003). Although muscarinic receptors are polytopic membrane proteins consisting of independent domains, the o3 loop cannot be considered an independent domain (Popot and Engelman, 1990; Maggio et al., 1993a,b; Novi et al., 2003). Therefore, observed effects of mutations in the o3 loop on cooperativity and affinity of the allosteric binding site should not be interpreted as indicative of a sole role of the o3 loop.
Our data point to an essential role of the o3 loop in the observed reversal of negative cooperativity between NMS and WGA or brucine. Replacement of the o2 loop in the M3wt receptor does not influence either affinity for WGA or cooperativity of WGA with NMS, or affinity for NMS. In the case of brucine that has the same affinity for both wild receptor subtypes, complete replacement of the o2 or the o3 extracellular loops and any mutations in the o3 loop expectedly do not influence its affinity. Similar to WGA, the exchange of the o2 loop has no influence on moderate negative cooperativity of brucine with NMS at M3wt receptor. Although tested strychnine-like allosteric modulators display both negative and positive cooperativity at M2wt receptor, the transposition of its o3 loop to M3wt receptor in all cases shifts cooperativity in one direction (Fig. 4A), i.e., decreases original negative or increases positive cooperativity. Out of five amino acids that differ between the o3 loops of the two receptors, the most important amino acids of the o3 loop of M2 receptor for this shift to become apparent are asparagine, valine, and threonine. Participation of these residues that are close to the seventh transmembrane domain corroborate the importance of this segment in allosteric interactions, namely, in determining affinity of allosteric modulator binding (Matsui et al., 1995; Buller et al., 2002; Voigtländer et al., 2003). However, in this context it is worth noting that the pattern of changes of cooperativity between [3H]NMS and strychnine-like allosteric modulators induced by mutations does not overlap with the pattern of their changes of affinity, e.g., gradual decrease of affinity of strychnine is accompanied by increase of cooperativity. Similarly, large increase of cooperativity of brucine is not associated with changes of affinity, and the large decrease of affinity for propargyl-WGA observed between mutants M3DKFN and M3SKFN is not accompanied with change of cooperativity (Fig. 4). This lack of correlation further demonstrates that amino acid residues essential for transmission of conformational change are not necessarily the same as those that form the binding site of allosteric modulators. A common transduction mechanism of cooperativity changes of all tested strychnine-like modulators is further supported by similar pattern of effects of gradual mutations (Fig. 4A)
The divergence of allosteric properties between strychnine, brucine, and WGA on one side and propargyl-WGA on the other side may be due to a difference in the locations to which they bind. Exchange of the entire o2 loop of the M3wt receptor with M2 sequence has no influence on affinity for NMS and thus in itself, unlike replacement of the o3 loop, does not induce a conformational change propagated to the orthosteric binding site. This modification, however, increases affinity for propargyl-WGA, hence indicating difference in binding of this allosteric modulator with the o2 loop of M2 and M3 receptors. The important role of the o2 loop of M2 receptor in the affinity for alcuronium, a compound structurally similar to a dimer of propargyl-WGA, and gallamine, a compound structurally dissimilar to tested strychnine-like modulators, was demonstrated (Gnagey et al., 1999; Krejí and Tuek, 2001). Similarly, interaction of these ligands with the o2 and the o3 loop of muscarinic M3 receptor was shown (Jakubík and Wess, 1999). Involvement of the o2 loop in high-affinity binding of propargyl-WGA on M2 receptor is in line with reported role of the o2 loop together with tyrosine 423 in the o3 loop in high-affinity binding of structurally different caracurine derivatives and alkane-bisammonium compounds to M2 receptor (Buller et al., 2002; Voigtländer et al., 2003). Together, these findings are compatible with and further support the view of muscarinic receptors as proteins with multiple allosteric binding sites (Lazareno et al., 2000; Birdsall et al., 2001).
Results of our experiments seem to be explained most easily on the assumption that an interplay of the o2 and the o3 extracellular loops plays a specific role in a conformational shift induced by binding of tested strychnine-like allosteric modulators and resulting cooperativity with [3H]NMS. WGA and brucine, whose binding to the o2 loop does not differ between M2wt and M3wt, display positive cooperativity with NMS at chimeric M3o3 receptor regardless of cooperativity they have on parent wild-type receptors. Strychnine and propargyl-WGA, whose binding is affected by exchange of the o2 loop, show more positive cooperativity at M3o3 in comparison with M3wt when parent receptors have positive cooperativity (strychnine) or less negative cooperativity when parent receptors have negative cooperativity (propargyl-WGA). Replacement of the o2 loop (chimera M3o2) slightly but significantly increases positive cooperativity of strychnine that is, however, much weaker than its positive cooperativity at M3o3 chimera. These observations suggest that the interaction of allosteric ligands with the o3 loop that was transposed from M2wt to create M3o3 chimera always induces conformational change, manifesting itself as positive cooperativity provided that there is no difference in interaction of allosteric modulator with o2 loop of M3 and M2 receptors as in the case of strychnine, brucine, and WGA. Different binding of propargyl-WGA (exhibiting strong negative cooperativity at parent wild-type receptors) to o2 loop of M3 and M2 receptor impedes this presumed conformational change and results in only reduction of negative cooperativity at M3o3 chimera. In line with this notion are results of experiments using M3o2 chimeric receptors. Complete replacement of the o2 loop of the M3wt receptor with that of M2wt does not change affinity for strychnine, brucine, and WGA and has little or no effect on cooperativity with NMS. On the other hand, propargyl-WGA displays higher affinity and a decrease in negative cooperativity with NMS at M3o2 chimera, which is significantly more pronounced than that at M3o3 chimera (more than 2 times).
In conclusion, the positive cooperativity of studied strychnine-like allosteric modulators with the binding of [3H]NMS is mainly determined by the o3 loop of the receptor, namely, by three amino acids—asparagine, valine, and threonine—located close to the seventh transmembrane domain of M2wt receptor. Their incorporation into the o3 loop of M3 receptor leads to manifestation of positive cooperativity between WGA and [3H]NMS, despite that both M2wt and M3wt receptors exert negative cooperativity. The reversal of original negative cooperativity at M3wt receptor to positive at M3o3 chimera is confined to WGA and brucine. Propargyl-WGA that has similarly to chemically closely related WGA negative cooperativity at both wild-type receptors does not exhibit this switch. Our data suggest that different epitopes on the outward oriented surface of muscarinic receptor are involved in binding of different allosteric modulators, whereas structures underlying the mechanism of allosteric interaction between allosteric modulators and orthosteric antagonist are similar. The dissimilarity of WGA and propargyl-WGA in binding to receptor is most likely due to the propargyl group and quaternary nitrogen (Fig. 1) that are apparently involved in interaction with the o2 loop and lead to high affinity for M2wt. However, differences in chemical structure among other tested strychnine-like modulators responsible for distinct allosteric interactions are not clear. To clarify this issue, more studies of allosteric modulators of various chemical structures and fitting structures of these modulators to a molecular model of muscarinic receptor will be required.
|
Acknowledgements |
|---|
ek in elaboration of the project and the most valuable help of Profs. E. E. El-Fakahany and N. J. Buckley. |
Footnotes |
|---|
ABBREVIATIONS: NMS, N-methylscopolamine; WGA, Wieland-Gumlich aldehyde; o2, second extracellular loop of receptor; o3, third extracellular loop of receptor; M3o2, chimeric receptor composed of M3 receptor with the o2 loop of M2 receptor; M3o3, chimeric receptor composed of M3 receptor with the o3 loop of M2 receptor; wt, wild-type.
Address correspondence to: Dr. J. Jakubík, Department of Neurochemistry, Institute of Physiology CAS, 14220 Prague, Czech Republic. E-mail: jakubik{at}biomed.cas.cz
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, and Sugimoto M (1999) Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol Pharmacol 55: 778–786.
Birdsall NJM, Lazareno S, Popham A, and Saldanha J (2001) Multiple allosteric sites on muscarinic receptors. Life Sci 68: 2517–2524.[CrossRef][Medline]
Bonner TI (1989a) The molecular basis of muscarinic receptor diversity. Trends Neurosci 12: 148–151.[CrossRef][Medline]
Bonner TI (1989b) New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci Suppl: 11–15.[Medline]
Bonner TI, Buckley NJ, Young AC, and Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science (Wash DC) 237: 527–532.
Bonner TI, Young AC, Brann MR, and Buckley NJ (1988) Cloning and expression of the human and rat M5 muscarinic acetylcholine receptor genes. Neuron 1: 403–410.[CrossRef][Medline]
Buckley NJ, Bonner TI, Buckley CM, and Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35: 469–476.[Abstract]
Buller S, Zlotos DP, Mohr K, and Ellis J (2002) Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands. Mol Pharmacol 61: 160–168.
Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54: 323–374.
Christopoulos A, Sorman JL, Mitchelson F, and El-Fakahany EE (1999) Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (C7/3-Phth) at cloned muscarinic acetylcholine receptors. Biochem Pharmacol 57: 171–179.[CrossRef][Medline]
Doleal V and Tuek S (1998) The effects of brucine and alcuronium on the inhibition of 3H-acetylcholine release from rat striatum by muscarinic receptor agonists. Br J Pharmacol 124: 1213–1218.[CrossRef][Medline]
Dong GZ, Kameyama K, Rinken A, and Haga T (1995) Ligand binding properties of muscarinic acetylcholine receptor subtypes (M1-M5) expressed in baculovirus-infected insect cells. J Pharmacol Exp Ther 274: 378–384.
Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33: 187–194.[Abstract]
Ellis J and Seidenberg M (1989) Gallamine exerts biphasic allosteric effects at muscarinic receptors. Mol Pharmacol 35: 173–176.[Abstract]
Ellis J and Seidenberg M (2000) Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors. Pharmacology 61: 62–69.[CrossRef][Medline]
Ellis J, Seidenberg M, and Brann MR (1993) Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44: 583–588.[Abstract]
Fredriksson R, Lagerstrom MC, Lundin LG, and Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. phylogenetic analysis, paralogon groups and fingerprints. Mol Pharmacol 63: 1256–1272.
Gnagey AL, Seidenberg M, and Ellis J (1999) Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol Pharmacol 56: 1245–1253.
Hulme EC, Lu ZL, and Bee MS (2003) Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor. Receptors Channels 9: 215–228.[CrossRef][Medline]
Jakubík J, Baáková L, el-Fakahany EE, and Tuek S (1995) Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J Pharmacol Exp Ther 274: 1077–1083.
Jakubík J, Baáková L, El-Fakahany EE, and Tuek S (1997) Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol 52: 172–179.
Jakubík J and Wess J (1999) Use of a sandwich enzyme-linked immunosorbent assay strategy to study mechanisms of G protein-coupled receptor assembly. J Biol Chem 274: 1349–1358.
Krejí A and Tuek S (2001) Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M3 receptors. Mol Pharmacol 60: 761–767.
Lazareno S and Birdsall NJM (1995) Detection, quantitation and verification of allosteric interaction of agents with labeled and unlabeled ligands at G-protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48: 362–378.[Abstract]
Lazareno S, Doleal V, Popham A, and Birdsall NJM (2004) Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol 65: 257–266.
Lazareno S, Popham A, and Birdsall NJM (2000) Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-3H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol 58: 194–207.
Lee NH, Hu J, and El-Fakahany EE (1992) Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the M1 muscarinic receptor. J Pharmacol Exp Ther 262: 312–316.
Leppik RA, Miller RC, Eck M, and Paquet JL (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the M2 muscarinic acetylcholine receptor. Mol Pharmacol 45: 983–990.[Abstract]
Lu ZL, Saldanha JW, and Hulme EC (2002) Seven-transmembrane receptors: crystals clarify. Trends Pharmacol Sci 23: 140–146.[CrossRef][Medline]
Lysíková M, Fuksová K, Elbert T, Jakubík J, and Tuek S (1999) Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxilic acid esters. Br J Pharmacol 127: 1240–1246.[CrossRef][Medline]
Maggio R, Vogel Z, and Wess J (1993a) Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett 319: 195–200.[CrossRef][Medline]
Maggio R, Vogel Z, and Wess J (1993b) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90: 3103–3107.
Matsui H, Lazareno S, and Birdsall NJ (1995) Probing of the location of the allosteric site on M1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47: 88–98.[Abstract]
Novi F, Scarselli M, Corsini GU, and Maggio R (2003) An unusual form of the association binding kinetics of N-[3H]methylscopolamine to the split muscarinic M2trunk/M2tail receptor. J Pharmacol Exp Ther 305: 786–795.
Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, and Capon DJ (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO (Eur Mol Biol Organ) J 6: 3923–3929.[Medline]
Popot JL and Engelman DM (1990) Membrane protein folding and oligomerization: the two-stage model. Biochemistry 29: 4031–4037.[CrossRef][Medline]
Proka J and Tuek S (1994) Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 45: 709–717.[Abstract]
Tränkle C, Kostenis E, and Mohr K (2001) Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity. Naunyn-Schmiedeberg's Arch Pharmacol 364: 172–178.[CrossRef][Medline]
Tuek S, Jakubík J, Doleal V, and El-Fakahany EE (1998) Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors. J Physiol (Lond) 92: 241–243.
Tuek S, Musílková J, Nedoma J, Proka J, Shelkovnikov S, and Vorlíek J (1990) Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol 38: 674–680.[Abstract]
Voigtländer U, Jöhren K, Mohr M, Raasch A, Tränkle C, Buller S, Ellis J, Höltje HD, and Mohr K (2003) Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors. Mol Pharmacol 64: 21–31.
This article has been cited by other articles:
|
|
 |
|
  W. Y. Chan, D. L. McKinzie, S. Bose, S. N. Mitchell, J. M. Witkin, R. C. Thompson, A. Christopoulos, S. Lazareno, N. J. M. Birdsall, F. P. Bymaster, et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia PNAS, August 5, 2008; 105(31): 10978 - 10983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jager, C. Schmalenbach, S. Prilla, J. Schrobang, A. Kebig, M. Sennwitz, E. Heller, C. Trankle, U. Holzgrabe, H.-D. Holtje, et al. Allosteric Small Molecules Unveil a Role of an Extracellular E2/Transmembrane Helix 7 Junction for G Protein-coupled Receptor Activation J. Biol. Chem., November 30, 2007; 282(48): 34968 - 34976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Prilla, J. Schrobang, J. Ellis, H.-D. Holtje, and K. Mohr Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity Mol. Pharmacol., July 1, 2006; 70(1): 181 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|
 |
 |
 |
), M2 wild-type receptor (
), M3o3 chimeric receptor (
), and M3o2 chimeric receptor (
). Calculated binding parameters are presented in 
), brucine (
), and WGA (